Last reviewed · How we verify
E-101 Solution 300 GU/ml — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
E-101 Solution 300 GU/ml (E-101 Solution 300 GU/ml) — Excited States, LLC. E-101 Solution 300 GU/ml is a therapeutic agent used in the treatment of various conditions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| E-101 Solution 300 GU/ml TARGET | E-101 Solution 300 GU/ml | Excited States, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- E-101 Solution 300 GU/ml CI watch — RSS
- E-101 Solution 300 GU/ml CI watch — Atom
- E-101 Solution 300 GU/ml CI watch — JSON
- E-101 Solution 300 GU/ml alone — RSS
Cite this brief
Drug Landscape (2026). E-101 Solution 300 GU/ml — Competitive Intelligence Brief. https://druglandscape.com/ci/e-101-solution-300-gu-ml. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab